PDL BioPharma Inc. (PDLI)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q1 2012 | |||||
| ≡ | Seth Klarman - Baupost Group | Sell 100.00% | 8,000,000 | 1.51 | |
| Q4 2011 | |||||
| ≡ | Seth Klarman - Baupost Group | Reduce 48.84% | 7,636,000 | 1.44 | |
| Q2 2011 | |||||
| ≡ | Seth Klarman - Baupost Group | Reduce 11.75% | 1,232,900 | 0.31 | |
| Q3 2009 | |||||
| ≡ | Seth Klarman - Baupost Group | Sell 100.00% | 12,657,500 | 9.67 | |
| Q2 2009 | |||||
| ≡ | Seth Klarman - Baupost Group | Reduce 18.65% | 2,902,108 | 2.22 | |
| Q3 2008 | |||||
| ≡ | Seth Klarman - Baupost Group | Reduce 6.51% | 964,540 | 0.55 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.